期刊文献+

我院2010年抗高血压药物用药分析 被引量:7

Use Analysis of Antihypertensive Drugs in Our Hospital in 2010
下载PDF
导出
摘要 目的了解医院抗高血压药物使用情况,为临床合理用药提供参考。方法对医院2010年抗高血压药的用药金额、用药频度、日用药金额、构成比等情况进行统计分析。结果钙通道阻滞剂在用药频度和用药金额上均居首位,单品种用药频度最高的是依那普利,用药金额最高的是左旋氨氯地平。结论抗高血压药物应用以长效钙通道阻滞剂为主,使用基本合理。 Objective To understand the circumstance of antihypertensive drugs us ed in our hospital to provide reference for the clinical drug use.Methods The am ount of money,frequency and proportion of antihypertensive drugs in our hospital during 2010 were collected and statistically analyzed.Results Calcium channel b lockers occupied the top place in medication frequency and amount of money.The h ighest frequency of single variety of drug was enalapril.The highest amount of m oney was levamlodipine.Conclusion Antihypertensive drugs are dominated by longterm action calcium channel blockers,their use is basically rational.
作者 张云秀
出处 《中国药业》 CAS 2012年第9期48-49,共2页 China Pharmaceuticals
关键词 抗高血压药 用药分析 合理用药 antihypertensive drugs medical analysis rational drug use
  • 相关文献

参考文献4

二级参考文献26

  • 1吴兆苏,姚崇华,赵冬,吴桂贤,王薇,刘静,曾哲淳,吴英恺.我国多省市心血管病趋势及决定因素的人群监测(中国MONICA方案)Ⅰ.发病率和死亡率监测结果[J].中华心血管病杂志,1997,25(1):6-11. 被引量:205
  • 2马锦华,刘倩,宋涛.厄贝沙坦治疗早期糖尿病肾病患者的临床研究[J].国际医药卫生导报,2007,13(13):74-76. 被引量:8
  • 3Mancia G,De Backer G,Dominiezak A,et al.2007 Guidelines for the management of arterial hypertension:the task force for the management of arterial hypertension of the European society of hype on (ESH) and of the European society of cardiology (ESC)[J].Journal of hypertension,2007,25 (6):1 105-1 187.
  • 4Hedblad B,Wikstrand J,Janzon L,et al.Low dosemetopmlol CR/XL and fluvastatin slow progression of carotid intima-media thickness:main results from the beta-blocker cholesterol-lowering asymptomatic plaque study (BCAPS)[J].Circulation,2001,103:1 721-1 726.
  • 5Resnick LM,I ester MH.Diferential efects of anfihypertensive drug therapy on arterial compliance[J].Am J Hypertens,2002,15:1 096-1 100.
  • 6中国高血压防治指南修订委员会.中国高血压防治指南(2005年修订版)[M].北京:人民卫生出版社,2005.
  • 7CHOBANIAN A V,BAKRIS G L,BLACK H R,et al.The seventh report of the joint national committee on prevention,detection,evaluation and treatment of high blood pressure:the JNC-7 report[J].JAMA,2003,289(22):2560-2572.
  • 8Guidelines Committee.2003 European Society of Hypertension European Society of Cardiology guidelines for the management of arterial hypertension[J].J Hypertens,2003,21:1021-1053.
  • 9ANON.Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic:The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)[J].JAMA,2002,288(23):2981 -2997.
  • 10JOUNELA A J,LILJA M,LUMMEJ,et al.Relation between low dose of hydrochlorothiazide,antihypertensive effect and adverse effects[J].Blood Press,1994,3:231-235.

共引文献589

同被引文献91

  • 1高淑兰,张子瑞,袁宝强.2001年~2004年我院口服抗高血压药物应用分析[J].中国药房,2006,17(5):355-357. 被引量:28
  • 2孙宁玲.抗高血压药物的器官保护研究进展[J].国际心血管病杂志,2006,33(2):70-72. 被引量:13
  • 3谷慧峰,黄晓敏,王永玲,薛海霞.漯河市抗高血压药物应用现状调查分析[J].中国药业,2006,15(21):53-53. 被引量:3
  • 4曾繁涛,谢杰.抗高血压药物临床用药分析[J].现代医药卫生,2007,23(15):2226-2228. 被引量:22
  • 5Messerli FH, Gr ossman E. Pedal edema-notall dihydropy ridlne calci- umant agonists are created equal. Am J Hy pertens,2002, 15: 1019- 1020.
  • 6牛林琳.抗高血压药物选择与合理应用[J].药物与临床:健康必读杂志,2012,6(6):365.
  • 7Borghi C,Tartagni E.The older patient with hypertension: care and cure[J].Ther Adv Chronic Dis,2012,3(5): 231 -236.
  • 8Fu P,Yang LL,Sun Y, et al .Target network differences between western drugs and Chinese herbal ingredients in treating cardio- vascular disease[J].BMC Bioinformatics, 2013,15 :s3.
  • 9Sharma M, Kothari C,Sherikar O, et al. Concurrent estimation of amlodipine besylate, hydrochlorothiazide and valsartan by RP - H PLC, HPTLC and UV- spectrophotometry [J]. Chromatogr Sci,2014, 52(1) :27- 35.
  • 10白毅.嘌呤能受体与抗血栓药物复合物晶体结构被解析[N].中国医药报,2014-04-22(05).

引证文献7

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部